Evidence map›Paper›PMID 26238291›Full record

ArticleArchives of toxicology2016

New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis.

Terezinha Souza, Danyel Jennen, Joost van Delft, Marcel van Herwijnen, Soterios Kyrtoupolos, Jos Kleinjans

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Ecotoxicological impacts of benzo[a]pyrene onFrontiers in immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Benzo[Frontiers in immunology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Modulatory Effects of Silymarin on Benzo[a]pyrene-Induced Hepatotoxicity.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Terezinha SouzaDepartment of Toxicogenomics, Maastricht University, 6229 ER, Maastricht, The Netherlands. terezinhamsouza@gmail.com.ORCID http://orcid.org/0000-0002-9580-3310
Danyel JennenDepartment of Toxicogenomics, Maastricht University, 6229 ER, Maastricht, The Netherlands.
Joost van DelftDepartment of Toxicogenomics, Maastricht University, 6229 ER, Maastricht, The Netherlands.
Marcel van HerwijnenDepartment of Toxicogenomics, Maastricht University, 6229 ER, Maastricht, The Netherlands.
Soterios KyrtoupolosInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635, Athens, Greece.
Jos KleinjansDepartment of Toxicogenomics, Maastricht University, 6229 ER, Maastricht, The Netherlands.
Maastricht University · NLNational Hellenic Research Foundation · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzo(a)pyrene (BaP) is a ubiquitous carcinogen resulting from incomplete combustion of organic compounds and also present at high levels in cigarette smoke. A wide range of biological effects has been attributed to BaP and its genotoxic metabolite BPDE, but the contribution to BaP toxicity of intermediary metabolites generated along the detoxification path remains unknown. Here, we report for the first time how 3-OH-BaP, 9,10-diol and BPDE, three major BaP metabolites, temporally relate to BaP-induced transcriptomic alterations in HepG2 cells. Since BaP is also known to induce AhR activation, we additionally evaluated TCDD to source the expression of non-genotoxic AhR-mediated patterns. 9,10-Diol was shown to activate several transcription factor networks related to BaP metabolism (AhR), oxidative stress (Nrf2) and cell proliferation (HIF-1α, AP-1) in particular at early time points, while BPDE influenced expression of genes involved in cell energetics, DNA repair and apoptotic pathways. Also, in order to grasp the role of BaP and its metabolites in chemical hepatocarcinogenesis, we compared expression patterns from BaP(-metabolites) and TCDD to a signature set of approximately nine thousand gene expressions derived from hepatocellular carcinoma (HCC) patients. While transcriptome modulation by TCDD appeared not significantly related to HCC, BaP and BPDE were shown to deregulate metastatic markers via non-genotoxic and genotoxic mechanisms and activate inflammatory pathways (NF-κβ signaling, cytokine-cytokine receptor interaction). BaP also showed strong repression of genes involved in cholesterol and fatty acid biosynthesis. Altogether, this study provides new insights into BaP-induced toxicity and sheds new light onto its mechanism of action as a hepatocarcinogen.

Indexed as

DNA Damage7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideBenzo(a)pyreneBenzopyrenesCarcinogens, EnvironmentalDihydroxydihydrobenzopyrenesDNA AdductsHep G2 CellsHumansLiver NeoplasmsTranscriptome3-hydroxybenzo(a)pyrene7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide9,10-dihydro-9,10-dihydroxybenzo(a)pyreneBenzo(a)pyreneBenzopyrenesCarcinogens, EnvironmentalDihydroxydihydrobenzopyrenesDNA AdductsBaP metabolitesBenzo(a)pyreneHepatocarcinogenesisHepatocellular carcinomaTranscriptomics

Identifiers

PMID26238291
PMCPMC4873527
OpenAlexW1882418526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.